ReviewFrontiers in endocrinology2023

Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity.

Isabella Zaffina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.